Neotropical Sylvatic Mosquitoes and Aedes aegypti Are Not Competent to Transmit 17DD Attenuated Yellow Fever Virus from Vaccinated Viremic New World Non-Human Primates

Viruses. 2022 Oct 11;14(10):2231. doi: 10.3390/v14102231.

Abstract

Beside humans, thousands of non-human primates (NHPs) died during the recent outbreak caused by the yellow fever virus (YFV) in Brazil. Vaccination of NHPs against YFV with the YF 17DD attenuated virus has emerged as a public health strategy, as it would reduce sylvatic transmission while also preserving endangered susceptible species. The hypothesis of establishing an uncontrolled transmission of this attenuated virus in nature was raised. We assessed vector competence of four sylvatic mosquito species, Haemagogus leucocelaenus, Haemagogus janthinomys/capricornii, Sabethes albiprivus, and Sabethes identicus, as well as the urban vector Aedes aegypti for YF 17DD attenuated vaccine virus when fed directly on eleven viremic lion tamarins or artificially challenged with the same virus. No infection was detected in 689 mosquitoes engorged on viremic lion tamarins whose viremia ranged from 1.05 × 103 to 6.61 × 103 FFU/mL, nor in those artificially taking ≤ 1 × 103 PFU/mL. Low viremia presented by YF 17DD-vaccinated New World NHPs combined with the low capacity and null dissemination ability in sylvatic and domestic mosquitoes of this attenuated virus suggest no risk of its transmission in nature. Thus, vaccination of captive and free-living NHPs against YFV is a safe public health strategy.

Keywords: YF 17DD; non-human primates; vector competence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aedes*
  • Animals
  • Humans
  • Leontopithecus*
  • Mosquito Vectors
  • Primates
  • Vaccines, Attenuated
  • Viremia / prevention & control
  • Yellow Fever* / epidemiology
  • Yellow Fever* / prevention & control
  • Yellow Fever* / veterinary
  • Yellow fever virus

Substances

  • Vaccines, Attenuated

Grants and funding

This research was funded by National Council for Scientific and Technological Development: CNPq grant no. 312446/2018; and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro: Grants nos. E-26/203.064/2016, E-26/202.431/2019 and E-26/201.335/2016.